A Phase 3 Study of AK112 Plus AK117 Versus Pembrolizumab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)

Clinical trial NCT06601335 · RECRUITING

Trial details

NCT number: NCT06601335
Sponsor: Akeso
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma

Start date: 2024-10-30
Primary completion: 2027-01-01
Enrollment: 510

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.